CONCERTO II CRT-D, CONSULTA DF4 ICD, CONSULTA ICD, MAXIMO II CRT-D, PROTECTA CRT-D, PROTECTA XT CRT-D
FDA premarket approval P010031/S362 · decided 2013-03-20
Approval details
- PMA number
- P010031
- Supplement
- S362
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- CONCERTO II CRT-D, CONSULTA DF4 ICD, CONSULTA ICD, MAXIMO II CRT-D, PROTECTA CRT-D, PROTECTA XT CRT-D
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2013-02-21
- Decision date
- 2013-03-20
- Days to decision
- 27 days
- Decision code
- OK30
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- IC MANUFACTURE TEST CHANGES FOR THE ADVISA DR IPG A4DR01, ADVISA MRI IPG A2DR01,CONSULTA CRT-P C4TR01, SYNCRA CRT-P C2TR01, CONCERTO II CRT-D D274TRK, CONSULTA DF4 ICD D204TRM, CONSULTA ICD D224TRK,MAXIMO II CRT-D D264TRM, D284TRK, PROTECTA CRT-D D334TRG, D334TRM, PROTECTA XT CRT-D D314TRG, D314TRM, MAXIMO II ICD D264DRM, D264VRM, D284DRG, D284VRC, PROTECTA ICDD334DRG, D334DRM, D334VRG, D334VRM, PROTECTA XT ICD D314DRG, D314DRM, D314VRG, D314VRM, SECURA ICD D204DRM, D204VRM, D224DRG, D224VRC, VI
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.